Relationship Between EBV and PTLD

Relationship Between Quantitative Epstein-Bar Viral(EBV) Titres and Post-Transplant Lymphoproliferative Disease

NCT00215033CI-TRIAL-00006525terminatedClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Why stopped (as posted): sufficient data gathered to support conclusion

Summary

Brief summary (as posted)

The purpose of this study is to determine the significance of an elevated quantitative EBV PCR and to determine the relationship between a EBV PCR value and the risk of developing PTLD.

Conditions

Conditions (1)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Pediatric Heart Transplant	—	UNRESOLVED	—

Interventions

Interventions (0)

Data not yet available

No intervention recorded.

Eligibility

Eligibility (as posted)

Sex: All

Show eligibility criteria text

Inclusion Criteria:

* patients undergone pediatric heart transplant
* followed by pediatric heart transplant program

Exclusion Criteria:

\-

References

Publications (0)

Data not yet available

No reference posted for this study.

Registry

Dates and enrollment

Start: Apr 1, 2005
Primary completion: —
Completion: May 1, 2006
First posted: Sep 22, 2005
Last update posted: Mar 16, 2012
Enrollment: 160 (actual)
Lead sponsor: Children's Healthcare of Atlanta OTHER
Keywords: Epstein-Barr virus, pediatric health, cardiac, heart transplant, lymphoproliferative disease, post-transplant, pediatric transplant

Data updated 22 days agoSource updated Mar 16, 2012source: clinicaltrials

Locations

Locations by country (1)

Country	Sites	Recruiting
United States	1	0

Trial listing is informational. Eligibility is decided by the study team; contact information is on ClinicalTrials.gov.